Outlook Therapeutics, Inc. announced that Alicia Tozier has been appointed as Senior Vice President, Marketing and Market Access. Ms. Tozier is a proven global commercialization leader with expertise across nine ophthalmology disease areas, and she has launched combination products spanning multiple modalities including medical devices, digital therapeutics and pharmaceuticals. Over the course of her career, she has led and scaled 60-plus person commercial launch teams and made significant contributions at leading companies such as Genentech, Astellas and Baxter.

Most recently, she oversaw commercialization launch efforts for two wet AMD therapies.